Income Statement Qiagen N.V.

Equities

QGEN

NL0015002SN0

Biotechnology & Medical Research

Market Closed - Nyse Other stock markets 04:00:03 2026-05-19 pm EDT			5-day change	1st Jan Change
34.24 ^USD	+1.36%		+1.60%	-27.67%

May. 19	Qiagen's Digital Insights Business to Integrate Nvidia's BioNeMo Platform	MT
May. 13	Qiagen N.V. Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 03:00 PM

e9e5966675ddb0488c6d19b9b12eaea1.fw_uTk_541FwluZIlV97kMgyhPp9AWYGs76l_q5c88M.PTeFLCGWsgs2xtAAwAYioqNZ6ZUodTZB6or6qt0KmLodZZw-FZC1ZjSjvw

Published financial data: QIAGEN N.V.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	2.25B	2.14B	1.97B	1.98B	2.09B
Total Revenues	2.25B	2.14B	1.97B	1.98B	2.09B
Cost of Goods Sold, Total	734M	696M	667M	657M	703M
Gross Profit	1.52B	1.45B	1.3B	1.32B	1.39B
Selling General & Admin Expenses, Total	584M	604M	579M	564M	584M
Stock-Based Compensation (IS)	-	-	-	-	-
R&D Expenses	190M	190M	199M	193M	188M
Amortization of Goodwill and Intangible Assets - (IS)	85.66M	75.01M	74.96M	68.14M	63.24M
Other Operating Expenses	-	-	-	-	-
Other Operating Expenses, Total	860M	869M	853M	826M	834M
Operating Income	658M	577M	445M	495M	553M
Interest Expense, Total	-54.48M	-58.36M	-53.41M	-43.84M	-33.26M
Interest And Investment Income	9.56M	40.26M	78.99M	68.02M	64.32M
Net Interest Expenses	-44.92M	-18.1M	25.58M	24.18M	31.06M
Income (Loss) On Equity Invest.	12M	3.8M	4.16M	5.72M	4.4M
Currency Exchange Gains (Loss)	-9M	2.7M	-5.8M	-4.5M	-8.4M
Other Non Operating Income (Expenses)	871K	-7.26M	84K	691K	-151K
EBT, Excl. Unusual Items	617M	558M	469M	521M	579M
Restructuring Charges	-2.36M	-900K	-6.95M	-386M	-58.96M
Merger & Related Restructuring Charges	-	-	-	-	-4.5M
Gain (Loss) On Sale Of Investments	36.8M	-	-4.16M	-2.65M	-2.5M
Gain (Loss) On Sale Of Assets	-	-	-	-	-
Asset Writedown	-	-12.97M	-	-	-
Legal Settlements	-4.7M	-	-	-	4.7M
Other Unusual Items	-20.7M	-31.3M	-28.36M	-10.8M	-27.94M
EBT, Incl. Unusual Items	626M	513M	430M	121M	490M
Income Tax Expense	113M	89.39M	88.51M	37.56M	65.38M
Earnings From Continuing Operations	513M	423M	341M	83.59M	425M
Net Income to Company	513M	423M	341M	83.59M	425M
Minority Interest	-	-	-	-	-
Net Income - (IS)	513M	423M	341M	83.59M	425M
Net Income to Common Incl Extra Items	513M	423M	341M	83.59M	425M
Net Income to Common Excl. Extra Items	513M	423M	341M	83.59M	425M
Per Share Items
Net EPS - Basic	2.51	2.08	1.67	0.41	2.06
Basic EPS - Continuing Operations	2.51	2.08	1.67	0.41	2.06
Basic Weighted Average Shares Outstanding	204M	204M	204M	206M	206M
Net EPS - Diluted	2.47	2.05	1.65	0.4	2.04
Diluted EPS - Continuing Operations	2.47	2.05	1.65	0.4	2.04
Diluted Weighted Average Shares Outstanding	208M	206M	207M	208M	208M
Normalized Basic EPS	1.89	1.71	1.43	1.58	1.76
Normalized Diluted EPS	1.85	1.69	1.42	1.57	1.74
Dividend Per Share	-	-	-	-	0.26
Payout Ratio	-	-	-	-	12.77
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	864M	774M	639M	685M	728M
EBITA	762M	670M	539M	580M	623M
EBIT	658M	577M	445M	495M	553M
EBITDAR	891M	801M	667M	716M	757M
Effective Tax Rate - (Ratio)	18.09	17.44	20.59	31	13.34
Current Domestic Taxes	1.71M	9.67M	11.39M	14.35M	1.75M
Current Foreign Taxes	117M	89.32M	66.38M	46.25M	83.7M
Total Current Taxes	119M	98.99M	77.78M	60.6M	85.45M
Deferred Domestic Taxes	-1.78M	-683K	-5.54M	9.14M	342K
Deferred Foreign Taxes	-3.51M	-8.92M	16.27M	-32.18M	-20.41M
Total Deferred Taxes	-5.29M	-9.6M	10.73M	-23.04M	-20.07M
Normalized Net Income	385M	349M	293M	326M	362M
Interest Capitalized	-	-	1.2M	2.6M	4.3M
Interest on Long-Term Debt	50.7M	55.1M	53.6M	45.2M	37.9M
Supplemental Operating Expense Items
Advertising Expense	13.5M	15.8M	11.5M	9.6M	8.7M
Selling and Marketing Expenses	456M	474M	460M	451M	458M
General and Administrative Expenses	128M	130M	119M	113M	126M
Research And Development Expense From Footnotes	190M	190M	199M	193M	188M
Net Rental Expense, Total	27.2M	27M	28.6M	30.6M	28.3M
Imputed Operating Lease Interest Expense	5.8M	6.25M	6.75M	7.06M	5.08M
Imputed Operating Lease Depreciation	21.4M	20.75M	21.85M	23.54M	23.22M
Maintenance & Repair Expenses, Total	16.2M	16.8M	19.3M	17.8M	21.6M
Stock-Based Comp., COGS (Total)	40K	2.58M	3.3M	4.32M	6.04M
Stock-Based Comp., R&D Exp. (Total)	4.91M	6.5M	7.48M	6.69M	8.25M
Stock-Based Comp., S&M Exp. (Total)	13.63M	16.08M	14.5M	12.12M	13.12M
Stock-Based Comp., G&A Exp. (Total)	19.81M	24.35M	21.82M	20.5M	22.99M
Stock-Based Comp., Other (Total)	-	-	-	-	-
Total Stock-Based Compensation	38.39M	49.51M	47.1M	43.63M	50.4M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	881M	731M	668M	664M	839M
Short Term Investments	185M	688M	390M	489M	260M
Total Cash And Short Term Investments	1.07B	1.42B	1.06B	1.15B	1.1B
Accounts Receivable, Total	376M	334M	397M	364M	413M
Other Receivables	64.32M	72.39M	98.82M	77.89M	89.72M
Notes Receivable	6.25M	29K	-	-	-
Total Receivables	447M	406M	496M	442M	502M
Inventory	328M	358M	398M	279M	302M
Prepaid Expenses	60.63M	50.96M	44.85M	41.77M	49.26M
Restricted Cash	11.2M	21.08M	87.67M	3.25M	22.53M
Other Current Assets, Total	198M	140M	63.14M	40.9M	20M
Total Current Assets	2.11B	2.39B	2.15B	1.96B	2B
Gross Property Plant And Equipment	1.37B	1.26B	1.39B	1.39B	1.54B
Accumulated Depreciation	-632M	-503M	-517M	-516M	-465M
Net Property Plant And Equipment	739M	758M	870M	870M	1.08B
Long-term Investments	33.48M	39.16M	23.72M	19.26M	17.35M
Goodwill	2.35B	2.35B	2.48B	2.43B	2.7B
Other Intangibles, Total	627M	545M	527M	304M	386M
Loans Receivable Long-Term	-	-	-	-	-
Deferred Tax Assets Long-Term	72.9M	56.3M	38.6M	70.1M	69M
Other Long-Term Assets, Total	214M	143M	32.48M	41.33M	35.63M
Total Assets	6.15B	6.29B	6.12B	5.69B	6.28B
Liabilities
Accounts Payable, Total	101M	98.73M	84.16M	83.27M	72.66M
Accrued Expenses, Total	172M	181M	170M	153M	181M
Current Portion of Long-Term Debt	848M	390M	588M	53.48M	18.19M
Current Portion of Leases	22.05M	22.22M	22.27M	24.34M	28.84M
Current Income Taxes Payable	27.67M	13.98M	12.48M	24.95M	39.72M
Unearned Revenue Current, Total	63.37M	69M	66.43M	70.83M	79.42M
Other Current Liabilities	283M	200M	136M	134M	92.21M
Total Current Liabilities	1.52B	975M	1.08B	544M	512M
Long-Term Debt	1.09B	1.51B	1.02B	1.34B	1.66B
Long-Term Leases	76.53M	71.41M	79.06M	96.66M	129M
Unearned Revenue Non Current	11.3M	15.2M	15.7M	18M	16.1M
Pension & Other Post Retirement Benefits	9.3M	7.2M	-	8.4M	9.2M
Deferred Tax Liability Non Current	37.59M	17.5M	-	22.7M	26.6M
Other Non Current Liabilities	303M	226M	113M	94.83M	151M
Total Liabilities	3.05B	2.82B	2.31B	2.12B	2.5B
Common Stock, Total	2.7M	2.7M	2.7M	2.6M	2.53M
Additional Paid In Capital	1.82B	1.87B	1.92B	1.67B	1.44B
Retained Earnings	1.79B	2.16B	2.46B	2.45B	2.75B
Treasury Stock	-190M	-160M	-133M	-74.92M	-31.82M
Comprehensive Income and Other	-327M	-404M	-434M	-475M	-377M
Total Common Equity	3.1B	3.47B	3.81B	3.57B	3.78B
Total Equity	3.1B	3.47B	3.81B	3.57B	3.78B
Total Liabilities And Equity	6.15B	6.29B	6.12B	5.69B	6.28B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	203M	204M	204M	205M	206M
ECS Total Common Shares Outstanding	203M	204M	204M	205M	206M
Book Value / Share	15.22	16.99	18.62	17.38	18.33
Tangible Book Value	118M	569M	805M	838M	691M
Tangible Book Value Per Share	0.58	2.79	3.94	4.08	3.35
Total Debt	2.04B	1.99B	1.71B	1.51B	1.83B
Net Debt	976M	574M	652M	360M	736M
Debt Equivalent Oper. Leases	218M	216M	229M	245M	226M
Equity Method Investments, Total	29.54M	26.9M	16.2M	11.8M	11.6M
Account Code - Inventory Valuation	3	3	3	3	3
Inventories - Raw Materials, Total	94.75M	97.61M	91.2M	52.77M	54.16M
Inventories - Work In Process, Total	67.68M	85.49M	94.74M	72.68M	78.42M
Inventories - Finished Goods, Total	165M	175M	212M	154M	169M
Land - (BS)	26.73M	25.48M	26.24M	24.94M	27.62M
Buildings, Total	372M	363M	383M	382M	409M
Machinery, Total	450M	384M	401M	362M	392M
Full Time Employees	5.59K	5.31K	5.19K	5.07K	5.65K
Part Time Employees	151	290	340	329	-
Accumulated Allowance for Doubtful Accounts (Supple)	23.12M	22.88M	17.3M	18.23M	19.54M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	513M	423M	341M	83.59M	425M
Depreciation & Amortization - CF	101M	104M	99.88M	105M	105M
Amortization of Goodwill and Intangible Assets - (CF)	104M	93.71M	93.76M	84.87M	70.34M
Depreciation & Amortization, Total	206M	198M	194M	190M	176M
Amortization of Deferred Charges, Total - (CF)	41.49M	44.5M	41.86M	31.43M	21.37M
(Gain) Loss on Sale of Investments - (CF)	-29.54M	6.23M	-	426K	968K
Asset Writedown & Restructuring Costs	-	12.97M	4.16M	203M	22.44M
Stock-Based Compensation (CF)	38.39M	49.51M	47.1M	43.63M	50.4M
Tax Benefit from Stock Options	-	-	-	-	-
Other Operating Activities, Total	334K	13.13M	18.35M	-14.65M	-6.96M
Change In Accounts Receivable	-7.4M	15.45M	-55.12M	12.22M	-36.39M
Change In Inventories	-81.8M	-61.95M	-44.79M	87.76M	-848K
Change In Accounts Payable	-5.98M	-1.76M	-22.42M	1.45M	-8.42M
Change In Income Taxes	-12.83M	-21.89M	-7.46M	25.53M	14.32M
Change in Other Net Operating Assets	-22M	38.27M	-57.18M	8.51M	-3.17M
Cash from Operations	639M	715M	459M	674M	654M
Capital Expenditure	-190M	-129M	-150M	-167M	-201M
Sale of Property, Plant, and Equipment	-	-	-	-	-
Cash Acquisitions	-	-63.65M	-150M	-	-291M
Divestitures	-	-	-	-	-
Sale (Purchase) of Intangible assets	-16.63M	-20.11M	-13.09M	-4.07M	-6.08M
Investment in Marketable and Equity Securities, Total	-40.74M	-504M	291M	-103M	225M
Other Investing Activities, Total	44.84M	-9.77M	-66.55M	25.41M	-32.16M
Cash from Investing	-202M	-727M	-87.66M	-249M	-305M
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	-	371M	-	494M	742M
Total Debt Issued	-	371M	-	494M	742M
Short Term Debt Repaid, Total	-	-	-	-	-
Long-Term Debt Repaid, Total	-41.34M	-480M	-437M	-602M	-534M
Total Debt Repaid	-41.34M	-480M	-437M	-602M	-534M
Issuance of Common Stock	7.92M	121K	36.92M	-	-
Repurchase of Common Stock	-124M	-25.36M	-17.68M	-326M	-307M
Common Dividends Paid	-	-	-	-	-54.24M
Common & Preferred Stock Dividends Paid	-	-	-	-	-54.24M
Other Financing Activities, Total	6.62M	7.98M	-16.32M	10.69M	-25.53M
Cash from Financing	-150M	-126M	-434M	-423M	-179M
Foreign Exchange Rate Adjustments	-3.68M	-12.54M	-558K	-5.96M	5.38M
Net Change in Cash	283M	-150M	-62.58M	-4.53M	175M
Supplemental Items
Cash Interest Paid	21.59M	23.21M	20.35M	24.18M	29.25M
Cash Income Tax Paid (Refund)	102M	98.56M	82.41M	15.68M	17.27M
Levered Free Cash Flow	463M	448M	157M	656M	257M
Unlevered Free Cash Flow	464M	451M	160M	665M	275M
Change In Net Working Capital	-6.48M	18.4M	208M	-280M	108M
Net Debt Issued / Repaid	-41.34M	-109M	-437M	-107M	208M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	6.84	5.8	4.49	5.24	5.77
Return on Total Capital	8.24	6.8	5.07	5.84	6.46
Return On Equity %	17.39	12.9	9.38	2.27	11.57
Return on Common Equity	17.39	12.9	9.38	2.27	11.57
Margin Analysis
Gross Profit Margin %	67.41	67.5	66.04	66.77	66.36
SG&A Margin	25.96	28.2	29.47	28.53	27.93
EBITDA Margin %	38.35	36.15	32.51	34.64	34.85
EBITA Margin %	33.85	31.3	27.43	29.31	29.8
EBIT Margin %	29.22	26.93	22.66	25.02	26.44
Income From Continuing Operations Margin %	22.77	19.76	17.37	4.23	20.33
Net Income Margin %	22.77	19.76	17.37	4.23	20.33
Net Avail. For Common Margin %	22.77	19.76	17.37	4.23	20.33
Normalized Net Income Margin	17.12	16.28	14.92	16.46	17.33
Levered Free Cash Flow Margin	20.55	20.91	7.98	33.15	12.3
Unlevered Free Cash Flow Margin	20.63	21.04	8.15	33.6	13.13
Asset Turnover
Asset Turnover	0.37	0.34	0.32	0.34	0.35
Fixed Assets Turnover	3.21	2.86	2.41	2.27	2.15
Receivables Turnover (Average Receivables)	5.88	6.03	5.38	5.2	5.38
Inventory Turnover (Average Inventory)	2.37	2.03	1.76	1.94	2.42
Short Term Liquidity
Current Ratio	1.39	2.46	1.99	3.61	3.9
Quick Ratio	0.99	1.87	1.44	2.93	3.13
Operating Cash Flow to Current Liabilities	0.42	0.73	0.43	1.24	1.28
Days Sales Outstanding (Average Receivables)	62.03	60.48	67.83	70.37	67.81
Days Outstanding Inventory (Average Inventory)	153.89	179.72	206.81	188.67	150.86
Average Days Payable Outstanding	51.99	50.23	47.15	56.94	39.21
Cash Conversion Cycle (Average Days)	163.93	189.98	227.49	202.11	179.45
Long Term Solvency
Total Debt/Equity	65.91	57.46	44.91	42.4	48.56
Total Debt / Total Capital	39.73	36.49	30.99	29.78	32.69
LT Debt/Equity	37.83	45.59	28.88	40.22	47.32
Long-Term Debt / Total Capital	22.8	28.95	19.93	28.24	31.85
Total Liabilities / Total Assets	49.62	44.87	37.73	37.3	39.85
EBIT / Interest Expense	12.08	9.88	8.34	11.29	16.61
EBITDA / Interest Expense	16.35	13.73	12.5	16.33	22.75
(EBITDA - Capex) / Interest Expense	12.87	11.52	9.69	12.51	16.7
Total Debt / EBITDA	2.29	2.49	2.56	2.11	2.43
Net Debt / EBITDA	1.1	0.72	0.98	0.5	0.97
Total Debt / (EBITDA - Capex)	2.91	2.96	3.3	2.76	3.3
Net Debt / (EBITDA - Capex)	1.39	0.85	1.26	0.66	1.32
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	20.39	-4.89	-8.23	0.66	5.65
Gross Profit, 1 Yr. Growth %	17.14	-4.78	-10.21	1.78	4.99
EBITDA, 1 Yr. Growth %	17.48	-10.35	-17.48	7.25	6.28
EBITA, 1 Yr. Growth %	18.97	-12.05	-19.59	7.57	7.42
EBIT, 1 Yr. Growth %	22.4	-12.35	-22.78	11.16	11.63
Earnings From Cont. Operations, 1 Yr. Growth %	42.71	-17.44	-19.35	-75.51	408.28
Net Income, 1 Yr. Growth %	42.71	-17.44	-19.35	-75.51	408.28
Normalized Net Income, 1 Yr. Growth %	29.14	8.35	-15.86	11.03	11.2
Diluted EPS Before Extra, 1 Yr. Growth %	44.44	-16.74	-19.56	-75.75	409.76
Accounts Receivable, 1 Yr. Growth %	-3.3	-11.35	19.01	-8.34	13.46
Inventory, 1 Yr. Growth %	12.48	9.29	11.29	-29.9	8.1
Net Property, Plant and Equip., 1 Yr. Growth %	11.66	2.52	14.86	-0.05	23.83
Total Assets, 1 Yr. Growth %	4.72	2.29	-2.74	-6.96	10.4
Tangible Book Value, 1 Yr. Growth %	-140.48	380.98	41.45	4.09	-17.54
Common Equity, 1 Yr. Growth %	10.68	11.95	9.84	-6.31	5.91
Cash From Operations, 1 Yr. Growth %	39.58	11.93	-35.76	46.6	-2.85
Capital Expenditures, 1 Yr. Growth %	43.01	-31.95	15.85	11.67	20.26
Levered Free Cash Flow, 1 Yr. Growth %	1K	1.47	-47.98	317.9	-61.83
Unlevered Free Cash Flow, 1 Yr. Growth %	948.39	1.69	-47.4	315.1	-59.78
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	21.45	7	-6.57	-3.89	3.12
Gross Profit, 2 Yr. CAGR %	18.73	5.61	-7.53	-4.4	3.37
EBITDA, 2 Yr. CAGR %	31.3	2.63	-13.99	-5.92	6.77
EBITA, 2 Yr. CAGR %	36.29	2.29	-15.91	0.28	18.28
EBIT, 2 Yr. CAGR %	51.2	3.58	-17.73	-7.35	11.4
Earnings From Cont. Operations, 2 Yr. CAGR %	251.64	8.55	-18.4	-55.56	11.57
Net Income, 2 Yr. CAGR %	251.64	8.55	-18.4	-55.56	11.57
Normalized Net Income, 2 Yr. CAGR %	60.15	-3.03	-13.09	-3.35	11.62
Diluted EPS Before Extra, 2 Yr. CAGR %	247.7	9.66	-18.17	-55.84	11.18
Accounts Receivable, 2 Yr. CAGR %	-1.86	-7.41	2.71	4.44	1.98
Inventory, 2 Yr. CAGR %	38.52	10.88	10.29	-11.68	-12.95
Net Property, Plant and Equip., 2 Yr. CAGR %	20.08	19.73	21.37	7.15	11.25
Total Assets, 2 Yr. CAGR %	8.35	2.99	-0.76	-4.88	1.35
Tangible Book Value, 2 Yr. CAGR %	-29.24	-13.7	66.11	21.34	-7.36
Common Equity, 2 Yr. CAGR %	10.49	18.16	15.41	1.44	-0.39
Cash From Operations, 2 Yr. CAGR %	38.98	24.99	-15.2	-2.96	19.34
Capital Expenditures, 2 Yr. CAGR %	26.89	-1.35	-11.21	13.74	15.88
Levered Free Cash Flow, 2 Yr. CAGR %	20.28	161.69	-48.32	47.44	28.01
Unlevered Free Cash Flow, 2 Yr. CAGR %	19.46	158.09	-47.87	47.76	30.93
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	14.45	11.95	1.66	-4.22	-0.81
Gross Profit, 3 Yr. CAGR %	12.74	10.31	0.05	-4.53	-1.37
EBITDA, 3 Yr. CAGR %	20.46	15.62	-4.57	-7.42	-2.02
EBITA, 3 Yr. CAGR %	21.64	17.77	-5.6	-8.71	2.61
EBIT, 3 Yr. CAGR %	29.23	26.08	-6.08	-9.05	-1.41
Earnings From Cont. Operations, 3 Yr. CAGR %	39.12	116.93	-1.69	-45.37	0.13
Net Income, 3 Yr. CAGR %	39.12	116.93	-1.69	-45.37	0.13
Normalized Net Income, 3 Yr. CAGR %	33.01	32.37	-7.51	-5.7	1.28
Diluted EPS Before Extra, 3 Yr. CAGR %	39.16	115.91	-1.1	-45.44	-0.19
Accounts Receivable, 3 Yr. CAGR %	2.28	-5.13	0.67	-1.11	7.36
Inventory, 3 Yr. CAGR %	26.21	28	11.01	-5.18	-5.52
Net Property, Plant and Equip., 3 Yr. CAGR %	13.04	13.92	18.08	13.76	12.44
Total Assets, 3 Yr. CAGR %	2.26	6.29	1.04	-2.87	-0.03
Tangible Book Value, 3 Yr. CAGR %	32.06	34.04	1.75	42.15	6.68
Common Equity, 3 Yr. CAGR %	5.53	10.97	15.32	7.66	2.91
Cash From Operations, 3 Yr. CAGR %	21.13	29.3	0.12	1.77	-2.92
Capital Expenditures, 3 Yr. CAGR %	20.05	3.09	4.08	-4.16	15.87
Levered Free Cash Flow, 3 Yr. CAGR %	16.21	11.87	33.88	3.73	-5.19
Unlevered Free Cash Flow, 3 Yr. CAGR %	15.51	11.46	33.28	4.1	-3.39
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	10.97	8.6	5.53	5.32	2.25
Gross Profit, 5 Yr. CAGR %	12.12	7.6	4.15	4.17	1.37
EBITDA, 5 Yr. CAGR %	16.53	12.14	5.27	6.47	-0.19
EBITA, 5 Yr. CAGR %	17.8	12.76	4.94	7.16	-0.56
EBIT, 5 Yr. CAGR %	27.13	19.77	7.87	11.46	0.55
Earnings From Cont. Operations, 5 Yr. CAGR %	44.88	59.97	12.38	15.06	3.42
Net Income, 5 Yr. CAGR %	44.84	59.97	12.38	15.06	3.42
Normalized Net Income, 5 Yr. CAGR %	29.82	23.2	12.36	16.72	-0.47
Diluted EPS Before Extra, 5 Yr. CAGR %	44.31	61.01	12.54	14.45	3.64
Accounts Receivable, 5 Yr. CAGR %	6.22	0.26	2.45	-1.41	1.19
Inventory, 5 Yr. CAGR %	19.12	18.08	19.58	10.34	0.72
Net Property, Plant and Equip., 5 Yr. CAGR %	11.1	8.92	11.21	11.16	15.3
Total Assets, 5 Yr. CAGR %	7.37	4.53	1.24	1.68	1.16
Tangible Book Value, 5 Yr. CAGR %	-1	81.66	73.38	28.81	-1.99
Common Equity, 5 Yr. CAGR %	3.5	6.41	7.64	7.06	8.76
Cash From Operations, 5 Yr. CAGR %	13.34	20.06	5.03	15.28	7.4
Capital Expenditures, 5 Yr. CAGR %	20.57	7.48	6.4	7.22	8.65
Levered Free Cash Flow, 5 Yr. CAGR %	6.2	23.39	-11.85	15.44	31.5
Unlevered Free Cash Flow, 5 Yr. CAGR %	6.04	22.57	-11.88	15.35	32.33